NSE ScannerComparison · NSE · data 2026-10-31
Fischer Medical Ventures Ltd vs S H Kelkar and Company Ltd
In plain words
Size: S H Kelkar and Company Ltd is about 1.1 times the market value of Fischer Medical Ventures Ltd.
Valuation (P/E): Fischer Medical Ventures Ltd 55.6 vs S H Kelkar and Company Ltd 19.5.
Return on equity: Fischer Medical Ventures Ltd 8.9% vs S H Kelkar and Company Ltd 5.3%.
Debt to equity: S H Kelkar and Company Ltd 0.76 vs Fischer Medical Ventures Ltd 0.28.
Differences in the numbers, not a recommendation of either stock.
Side by side
| FISCHER | SHK | |
|---|---|---|
| Price | ₹24.79 | ₹125.34 |
| Market cap | ₹1,620 cr | ₹1,740 cr |
| P/E | 55.6 | 19.5 |
| P/B | — | — |
| ROE | 8.9% | 5.3% |
| ROCE | 12.8% | 8.5% |
| Debt / equity | 0.28 | 0.76 |
| Operating margin | 12.7% | 5.3% |
| Dividend yield | 0.20% | 1.59% |
| Sales growth, 3 years (yearly) | 1097.9% | 12.0% |
| Profit growth, 3 years (yearly) | — | 4.2% |
| 1-year return | -78.8% | -44.9% |
| Revenue, last 12 months | ₹367 cr | ₹2,450 cr |
| Net profit, last 12 months | ₹30 cr | ₹89 cr |
| Latest quarter | — | Sept 2024 |
| Quarter net profit | — | ₹40 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 63.08% | 54.87% |
| Health check | Weak (2.9/10) | Average (4.8/10) |
Common questions
Which has a higher P/E, Fischer Medical Ventures Ltd or S H Kelkar and Company Ltd?
Fischer Medical Ventures Ltd trades at the higher P/E (55.6 against 19.5). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Fischer Medical Ventures Ltd (8.9% against 5.3%).
Which carries more debt?
S H Kelkar and Company Ltd has the higher debt-to-equity ratio (0.76 against 0.28).